EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3′-diaminobenzidine-stained esophageal biopsies

John Plate iD, Mogens Bove, Helen M Larsson, Elisabeth Norder Grusell, Nabanita Chatterjee, Leif E Johansson, Henrik Bergquist

Diseases of the Esophagus · 2024

DOI: 10.1093/dote/doae034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, 2024. Verfasst von John Plate und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, NU-Hospital Group, Region Västra Götaland, Trollhättan, Sweden. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type II, Gastroesophageal Reflux, Eosinophilic Esophagitis, Tyrosine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic esophagitis (EoE) and gastroesophageal reflux disease (GERD) share many histopathological features; therefore, markers for differentiation are of diagnostic interest and may add to the understanding of the underlying mechanisms. The nitrergic system is upregulated in GERD and probably also in EoE. Esophageal biopsies of patients with EoE (n = 20), GERD (n = 20), and healthy volunteers (HVs) (n = 15) were exposed to antibodies against inducible nitric oxide synthase (iNOS), nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3. The stained object glasses were randomized, digitized, and blindly analyzed regarding the expression of DAB (3,3′-diaminobenzidine) by a protocol developed in QuPath software. A statistically significant overexpression of iNOS was observed in patients with any of the two inflammatory diseases compared with that in HVs. Eotaxin-3 could differentiate HVs versus inflammatory states. Gastroesophageal reflux patients displayed the highest levels of nitrotyrosine. Neither iNOS nor nitrotyrosine alone were able to differentiate between the two diseases. For that purpose, eosinophil peroxidase was a better candidate, as the mean levels increased stepwise from HVs via GERD to EoE. iNOS and nitrotyrosine are significantly overexpressed in patients with EoE and GERD compared with healthy controls, but only eosinophil peroxidase could differentiate the two types of esophagitis. The implications of the finding of the highest levels of nitrotyrosine among gastroesophageal reflux patients are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric Oxide Synthase Type IIGastroesophageal RefluxEosinophilic EsophagitisTyrosine3,3'-DiaminobenzidineEosinophil PeroxidaseChemokine CCL26Galectin 3HumansFemaleMaleAdultMiddle AgedBiopsyCase-Control StudiesEsophagusBiomarkersChemokine CCL24Young AdultAgedImmunohistochemistry

Stichwörter der Autor:innen

eosinophilic esophagitisgastroesophageal reflux diseaseimage analysisimmunohistochemistry

Substanzen

Nitric Oxide Synthase Type IITyrosine3-nitrotyrosine3,3'-DiaminobenzidineEosinophil PeroxidaseChemokine CCL26Galectin 3BiomarkersChemokine CCL24CCL26 protein, human

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, NU-Hospital Group, Region Västra Götaland, Trollhättan, Sweden.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Kungsbacka Hospital, Region Halland, Kungsbacka, Sweden.
  • Core Facilities, Centre for Cellular Imaging (CCI), University of Gothenburg, Gothenburg, Sweden.
  • Department of ENT, Head and Neck Surgery, Skövde County Hospital, Region Västra Götaland, Skövde, Sweden.

ORCID-Profile: John Plate

Zitieren

APA

Plate, J., Bove, M., Larsson, H. M., Norder Grusell, E., Chatterjee, N., Johansson, L. E., & Bergquist, H. (2024). Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3′-diaminobenzidine-stained esophageal biopsies. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae034

Vancouver

Plate J, Bove M, Larsson HM, Norder Grusell E, Chatterjee N, Johansson LE, et al. Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3′-diaminobenzidine-stained esophageal biopsies. Diseases of the Esophagus. 2024. doi:10.1093/dote/doae034

BibTeX
@article{Plate2024,
  author = {Plate, John and Bove, Mogens and Larsson, Helen M and Norder Grusell, Elisabeth and Chatterjee, Nabanita and Johansson, Leif E and Bergquist, Henrik},
  title = {Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3′-diaminobenzidine-stained esophageal biopsies},
  journal = {Diseases of the Esophagus},
  year = {2024},
  doi = {10.1093/dote/doae034}
}
Kostenlos starten →